Athira Pharma, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2020 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Athira Pharma, Inc. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2020 to Q1 2023.
  • Athira Pharma, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $99K, a 52.9% decline year-over-year.
  • Athira Pharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $493K, a 24.6% decline from 2022.
  • Athira Pharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $654K, a 99.3% decline from 2021.
  • Athira Pharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $97.1M, a 66.8% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $99K -$111K -52.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2022 $210K -$97M -99.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $97.2M +$95.4M +5183% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $1.84M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.